Medical Device Network on MSN
Countable Labs raises $26M for PCR technology advancement
Countable Labs claims that its Countable PCR technology is “at least 10 times” more sensitive than conventional PCR.
Countable PCR delivers single-molecule precision for Europe's most demanding quantification challenges — from cell and gene therapy manufacturing to biomarker validation, diagnostics, commercial ...
Countable Labs raises $26 million. Company shares plans for new products to support clinical testing applications and announces hire of sales leader.
Countable Labs (formerly Enumerix) enters the genomics market with the launch of Countable PCR, redefining what's possible with PCR for rare event detection. By delivering 10 times more sensitivity ...
Countable Labs raises $26 million to develop advanced single-molecule PCR tools, expanding precision diagnostics for global ...
DNA and RNA are central to laboratory and clinical research, where quantifying their abundance is key to applications such as gene expression analysis, cell and gene therapy development, and ...
As the need for more sensitive and precise molecular quantification grows across translational research, diagnostics, and therapeutic development, conventional PCR workflows can fall short. Detecting ...
Countable PCR is a highly scalable, digital PCR-like technology that achieves the highest sensitivity and precision of any PCR technology on the market. With more than 10 times the sensitivity and ...
PALO ALTO, Calif., May 13, 2025--(BUSINESS WIRE)--Countable Labs (formerly Enumerix) enters the genomics market with the launch of Countable PCR, redefining what’s possible with PCR for rare event ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results